期刊文献+

抗人生长转化因子15单克隆抗体制备及鉴定 被引量:5

Preparation and identification of monoclonal antibody against human growth differentiation factor 15
下载PDF
导出
摘要 目的:制备抗人生长转化因子15(GDF15)单克隆抗体(mAb)并鉴定其特性。方法:构建GDF15原核表达载体pGEX-4T-2-gdf15,诱导表达并纯化GST-GDF15融合蛋白。以该融合蛋白免疫BALB/c小鼠,取小鼠的脾细胞与同系小鼠Sp2/0骨髓瘤细胞常规融合,依次进行阳性杂交瘤细胞株的筛选及亚克隆,最终获得稳定分泌抗GDF15 mAb杂交瘤细胞株。以间接ELISA法检测抗体效价;Western blot鉴定抗体特异性;免疫共沉淀法初步检测在肝癌患者血清中GDF15表达水平。结果:获得1株稳定分泌抗人GDF15 mAb杂交瘤细胞株,命名为9G3;抗体免疫球蛋白亚类为IgG1,轻链为κ型;免疫共沉淀及质谱分析证实抗GDF15 mAb9G3能与肝癌患者血清中GDF15蛋白特异性结合并且GDF15水平在肝癌患者血清中较正常人显著升高。结论:成功制备了抗人GDF15mAb,为后期肝癌早期诊断试剂盒的开发奠定了良好的基础。 AIM: To prepare the monoclonal antibody(mAb) against human growth differentiation factor 15(GDF15).METHODS: The expression vector pGEX-4T-2-gdf15 was constructed and transformed into E.coli Top10F' for expression.Then the purified fusion protein was used to immunize the BALB/c mice.The mouse myeloma cells(Sp2/0) were fused with spleen cells from the BALB/c immunized by the purified protein.Subsequently,limited dilution method was used three times to screen hybridoma cell lines.The titer of the mAb was detected by ELISA and its specificity was analyzed by Western blot.The serum level of GDF15 in hepatocellular carcinoma(HCC) and health people was measured by co-immunoprecipitation(IP)method.RESULTS: The GST-GDF15 fusion protein was successfully expressed and purified.One hybridoma cell line designated 9G3 against GDF15 was obtained.IP and mass spectrometric analysis revealed that the mAb recognized GDF15 in human sera with high specificity.The level of GDF15 in HCC patients was much higher than that in health people.CONCLUSION: The success in mouse anti-GDF15 mAb preparation provides the basis for further developing HCC diagnose kit.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2011年第5期539-541,544,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 卫生部科学研究基金资助项目(wkj2004-2-12) 南京医科大学肿瘤中心招标课题(08ZIKf06)
关键词 GDF15 单克隆抗体 HCC GDF15 monoclonal antibody(mAb) HCC
  • 相关文献

参考文献11

  • 1Shariff MI, Cox IJ, Gomaa AI, et al. Hepatocellular carcinoma: cur- rent trends in worldwide epidemiology, risk factors, diagnosis and therapeutics[J]. Expt Rev Gastroenterel Hepatol, 2009, 3:353 - 367.
  • 2Poon D, Anderson BO, Chen LT, et al. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Sum- mit 2009[J] .Lancet Oncol, 2009, 10:1111-1118.
  • 3Liu T, Bauskin AB, Zaunders J, et al. Macrophage inhibitory cyto- kine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells[J]. Cancer Res, 2003, 63(16): 5034-5040.
  • 4Brown DA, Bauskin AR, Fairlie WD, et al. Antibody-based approach to high-volume genotyping for MIC-1 polymorphism [ J ]. Biotech- niques, 2002, 33(1) : 118 -120.
  • 5查斌山,刘开坤,刘悦芳,周顺,朱进,冯振卿,王轩,张建平.SPP-1、GDF-15和CXCL-1在人小肝癌中表达的初步研究[J].武汉大学学报(医学版),2009,30(1):38-42. 被引量:3
  • 6刘开坤,查斌山,刘悦芳,朱进,冯振卿,张建平.GDF15在大鼠早期肝癌和人小肝癌组织中的表达[J].南京医科大学学报(自然科学版),2008,28(4):439-444. 被引量:4
  • 7周群芳,鞠吉雨,郎景和.抗人骨桥蛋白单克隆抗体的制备及鉴定[J].细胞与分子免疫学杂志,2009,25(1):62-64. 被引量:5
  • 8Albertoni M, Shaw PH, Nozaki M, et al. Anoxla induces macrophage inhibitory cytokine-1 ( MIC-1 ) in glioblastoma cells independently of p53 and HIF-1 [J]. Oncogene, 2002, 21(27) : 4212-4219.
  • 9Bauskin AR, Brown DA, Kuffner T, et al. Role of macrophage inhibi- tory cytokine-1 in tumorigenesis and diagnosis of cancer [ J ]. Cancer Ros, 2006, 66(10): 4983-4986.
  • 10Hsu CM, Hsu YA, Tsai Y, et al. Emodin inhibits the growth of hep- aroma cells: finding the common anti-cancer pathway using Huh7, Hep3B, and HepG2 cells [ J]. Biochem Biophys Res Commun, 2010, 392(4) : 473 -478.

二级参考文献32

  • 1马彩虹,陈贵安,韩劲松,齐永芬.骨桥蛋白在人正常月经周期子宫内膜的表达[J].生殖医学杂志,2006,15(1):1-5. 被引量:7
  • 2Khan SA, Cook AC, Kappil M, et al. Enhanced cell surface CD44 variant( v6, v9 )expression by osteopontin in breast cancer epithelial ceils facilitates tumor cell migration: Novel post transcriptional, post translational regulation [ J ]. Clin Exp Metastasis, 2005, 22 ( 8 ) : 663 - 673.
  • 3Rittling SR, Chambers AF. Role of osteopontin in tumor progression [J]. Br J Cancer, 2004, 90(10) : 1877 - 1551.
  • 4Kim JH, Skates SJ, Uede T, et al. Osteopontin as a potential diagnostic biomarker for ovarian cancer[ J]. JAMA, 2002, 287 ( 13 ) : 1671 - 1679.
  • 5White FJ, Ross JW, Joyce MM, et al. Steroid regulation of cell specitic secreted phosphoprotein 1 (osteopontin)expression in the pregnant porcine uterus[J].Biol Reprod, 2005, 73 (6) : 1294 - 1301.
  • 6Weintraub AS, Lin X, Itskovich VV, et al. Prenatal detection of embryo resorption in osteopontin deficient mice using serial noninvasive magnetic respane microscopy[ J]. Pediatr Res, 2004, 55 (3) : 419 - 424.
  • 7Helluint O, Chan C, Vilaire G, et al. The activation state of αvβ3 regulates platelet and lymphocyte adhesion to intact and thrombin cleaved osteopontin [ J ]. J Biol Chem, 2000, 275 (24) : 18337 - 18343.
  • 8Song BC, Chung YH, Kim JA, et al. Transforming growth factor-beta1 as a useful serologic marker of small hepatocellular carcinoma[J].Cancer, 2002, 94 (1): 175-180.
  • 9Welsh JB, Sapinoso I.M, Kern SG, et al. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum[J].PNAS, 2003, (100):3 410-3 415
  • 10Liu Y, Zhu X, Zhu J, et al. Identification of differential expression of genes in hepatocellular carcinoma by suppression subtractive hybridization combined cDNA microarray [J]. Oncology Reports, 2007, 18(4): 943-951.

共引文献9

同被引文献63

  • 1刘侃,汪炬,谢秋玲,李志英,洪岸.重组类胰岛素样生长因子-Ⅰ的纯化与复性[J].中国生物工程杂志,2006,26(2):29-33. 被引量:14
  • 2Jemal A,Bray F,Center MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-90.
  • 3Colli A,Fraquelli M,Conte D.Alpha-fetoprotein and hepato-cellular carcinoma[J].Am J Gastroenterol,2006,101(8):1939-1941.
  • 4Kladney RD,Cui X,Bulla GA,et al.Expression of GP73,aresident Golgi membrane protein,in viral and nonviral liverdisease[J].Hepatology,2002,35(6):1431-1440.
  • 5Marrero JA,Romano PR,Nikolaeva O,et al.GP73,a residentGolgi glycoprotein,is a novel serum marker for hepatocellularcarcinoma[J].J Hepatol,2005,43(6):1007-1012.
  • 6Riener MO,Stenner F,Liewen H,et al.Alpha-fetoproteinand serum golgi phosphoprotein 2are equally discriminative indetecting early hepatocellular carcinomas.[J].Hepatology,2009,50(1):326.
  • 7El-Serag HB.Epidemiology of viral hepatitis and hepato-cellular carcinoma[J].Gastroenterology,2012,142(6):1264-1273.
  • 8Trevisani F,Cantarini MC,Wands JR,et al.Recent advancesin the natural history of hepatocellular carcinoma[J].Carcinogenesis,2008,29(7):1299-1305.
  • 9Kladney RD,Bulla GA,Guo L,et al.GP73,a novel Golgi-localized protein upregulated by viral infection[J].Gene,2000,249(1-2):53-65.
  • 10Block TM,Comunale MA,Lowman M,et al.Use of targetedglycoproteomics to identify serum glycoproteins that correlatewith liver cancer in woodchucks and humans[J].Proc NatlAcad Sci USA,2005,102(3):779-784.

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部